Effects of Oxymatrine from Ku Shen on Cancer Cells

被引:37
作者
Ho, John W. [1 ]
Hon, Parry Lee Ngan [1 ]
Chim, Wai On [2 ]
机构
[1] CUHK, Dept Biochem, Shatin, Hong Kong, Peoples R China
[2] CUHK, Environm Sci Programme, Shatin, Hong Kong, Peoples R China
关键词
Oxymatrine; matrine; hepatoma cells; inhibition; cancer; ORTHOTOPIC LIVER-TRANSPLANTATION; SINUSOIDAL ENDOTHELIAL-CELLS; REPERFUSION INJURY; RANDOMIZED-TRIALS; GLYCYRRHETIC ACID; HERBAL MEDICINES; COPTIDIS RHIZOMA; TEA POLYPHENOLS; HEPATOMA-CELLS; COLD ISCHEMIA;
D O I
10.2174/187152009789124673
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oxymatrine is one of active constituents isolated from Ku Shen, which is the dried root of Sophora flavescens Ait. The herb used in different herbal formulations is commonly known with specific pharmacological properties for treatment of liver disorders and other diseases such as arrhythmia, eczema and skin disorders, leukopenia and bronchitis. Sophora flavescens Ait is known to enhance liver functions and reduce hepatotoxicity due to oxidative stress and liver injury. The protection of cells from chemical toxicity is important in reducing liver damage. Reduction of oxidative stress by active components of herbal medicines is shown to be beneficial and important in regulating the normal functions of the liver. In this study, effects of oxymatrine on cancer cells after treatment of the cell line with DMSO were reported. This review described for cells without oxymatrine pre-treatment, cell injury was implicated as indicated by the decrease in cell viability. Ku Shen showed protective effects on cells from the DMSO-induced toxicity. The results show that oxymatrine can inhibit the G(2) and M phase of H4IIE. The findings suggest that anti-inflammatory constituents such as oxymatrine could mediate cell division of cancer cells and reduce cell cytotoxicity due probably to its capacity to inhibit the metabolic activation of hepato-toxin, a critical factor in the pathogenesis of chemical-induced liver injury.
引用
收藏
页码:823 / 826
页数:4
相关论文
共 36 条
[21]   Synthetic analogs of green tea polyphenols as proteasome inhibitors [J].
Smith, DM ;
Wang, ZG ;
Kazi, A ;
Li, LH ;
Chan, TH ;
Dou, QP .
MOLECULAR MEDICINE, 2002, 8 (07) :382-392
[22]   Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells [J].
Song, GB ;
Luo, Q ;
Qin, J ;
Wang, L ;
Shi, YS ;
Sun, CX .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2006, 48 (01) :1-5
[23]   Phlorotannin-protein interactions [J].
Stern, JL ;
Hagerman, AE ;
Steinberg, PD ;
Mason, PK .
JOURNAL OF CHEMICAL ECOLOGY, 1996, 22 (10) :1877-1899
[24]   Production of bioactive triterpenes by Eriobotrya japonica calli [J].
Taniguchi, S ;
Imayoshi, Y ;
Kobayashi, E ;
Takamatsu, Y ;
Ito, H ;
Hatano, T ;
Sakagami, H ;
Tokuda, H ;
Nishino, H ;
Sugita, D ;
Shimura, S ;
Yoshida, T .
PHYTOCHEMISTRY, 2002, 59 (03) :315-323
[25]   Simultaneous determination of oxymatrine and its active metabolite matrine in dog plasma by liquid chromatography-mass spectrometry and its application to pharmacokinetic studies [J].
Wang, SJ ;
Wang, GJ ;
Li, XT ;
Sun, JG ;
Ma, RL ;
Sheng, LS .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 817 (02) :319-325
[26]  
Wang Y. S., 1983, PHARM APPL CHINESE M
[27]   Spasmolytic effects of Baccharis conferta and some of its constituents [J].
Weimann, C ;
Göransson, U ;
Pongprayoon-Claeson, U ;
Claeson, P ;
Bohlin, L ;
Rimpler, H ;
Heinrich, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (01) :99-104
[28]  
Xiang XX, 2002, CHINESE MED J-PEKING, V115, P593
[29]   Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase [J].
Xu, GL ;
Yao, L ;
Rao, SY ;
Gong, ZN ;
Zhang, SQ ;
Yu, SQ .
JOURNAL OF ETHNOPHARMACOLOGY, 2005, 98 (1-2) :177-183
[30]   Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice [J].
Yang, Huanjie ;
Chen, Di ;
Cui, Qiuzhi Cindy ;
Yuan, Xiao ;
Dou, Q. Ping .
CANCER RESEARCH, 2006, 66 (09) :4758-4765